A Direct Rapid Phenotypic Antimicrobial Susceptibility Test Enables Early Selection of Optimal Antibiotics to Treat Bacteremia in COVID-19 Patients

BACKGROUND: Co-infection with bacteria and severe acute respiratory syndrome coronavirus 2 may result in greater use of healthcare resources and a poor prognosis. Therefore, early selection and use of optimal antibiotics are essential. The direct rapid antibiotic susceptibility test (dRAST) can dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Do Hyeon, Chang, Euijin, Kang, Chang Kyung, Choe, Pyoeng Gyun, Kim, Nam Joong, Kim, Taek Soo, Park, Wan Beom, Oh, Myoung-don
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731248/
https://www.ncbi.nlm.nih.gov/pubmed/34979608
http://dx.doi.org/10.3947/ic.2021.0139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731248/
https://www.ncbi.nlm.nih.gov/pubmed/34979608
http://dx.doi.org/10.3947/ic.2021.0139

Ejemplares similares